Catherine François
- Hepatology top 1%
- Hepatitis C virus research 33
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 9
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 7
- Cancer Research top 10%
- Epidemiology top 5%
- Hepatitis B Virus Studies 19
- Liver Disease Diagnosis and Treatment 10
- Virology top 10%
-
- Polyomavirus and related diseases 9
-
- Systemic Lupus Erythematosus Research 9
Catherine François
61 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Hepatology 541
- Infectious Diseases 435
- Cancer Research 268
- Epidemiology 478
- Virology 56
Countries citing papers authored by Catherine François
This map shows the geographic impact of Catherine François's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine François with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine François more than expected).
Fields of papers citing papers by Catherine François
This network shows the impact of papers produced by Catherine François. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine François. The network helps show where Catherine François may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Catherine François, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 1 | |
| 5 | 2020 | 48 | |
| 6 | 2020 | 32 | |
| 7 | 2020 | 32 | |
| 8 | 2019 | 3 | |
| 9 | 2014 | 29 | |
| 10 | 2014 | 42 | |
| 11 | The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cellsbreakdown → | 2014 | 315 |
| 12 | 2013 | 6 | |
| 13 | 2013 | 37 | |
| 14 | 2013 | 20 | |
| 15 | 2011 | 9 | |
| 16 | 2010 | 43 | |
| 17 | 2008 | 8 | |
| 18 | 2007 | 19 | |
| 19 | 2004 | 9 | |
| 20 | 2002 | 22 |
About Catherine François
Catherine François is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Rheumatology and Virology, having authored 62 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (33 papers), Hepatitis B Virus Studies (19 papers), Liver Disease Diagnosis and Treatment (10 papers), Polyomavirus and related diseases (9 papers), Systemic Lupus Erythematosus Research (9 papers), HIV/AIDS drug development and treatment (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and COVID-19 Clinical Research Studies (7 papers). The work is most often cited by research in Hepatology (541 citations), Infectious Diseases (435 citations), Cancer Research (268 citations), Epidemiology (478 citations) and Virology (56 citations). Catherine François has collaborated with scholars based in France, Belgium and Lebanon. Frequent co-authors include Sandrine Castelain, Gilles Duverlie, Étienne Brochot, François Helle, Virginie Morel, Véronique Descamps, Antoine Galmiche, Christophe Louandre, Corinne Godin and Zuzana Saidak. Their work appears in journals such as Journal of Clinical Virology, PLoS ONE, Journal of Clinical Microbiology, Journal of Medical Virology and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.